Retinitis Pigmentosa (RP) is a group of progressive inherited retinal dystrophies that cause visual impairment as a result of photoreceptor cell death. RP is heterogeneous, both clinically and genetically making difficult to establish precise genotype-phenotype correlations. In a Spanish family with autosomal recessive RP (arRP), homozygosity mapping and whole exome sequencing led to the identification of a homozygous mutation (c.358_359delGT; p.Ala122Leufs*2) in the ZNF408 gene. A screening performed in 217 additional unrelated families revealed another homozygous mutation (c.1621C>T; p.Arg541Cys) in an isolated RP case. ZNF408 encodes a transcription factor that harbors ten predicted C2H2-type fingers thought to be implicated in DNA binding. To elucidate the ZNF408 role in the retina and the pathogenesis of these mutations we have performed different functional studies. By immunohistochemical analysis in healthy human retina, we identified that ZNF408 is expressed in both cone and rod photoreceptors, in a specific type of amacrine and ganglion cells, and in retinal blood vessels. ZNF408 revealed a cytoplasmic localization and a nuclear distribution in areas corresponding with the euchromatin fraction. Immunolocalization studies showed a partial mislocalization of the p.Arg541Cys mutant protein retaining part of the WT protein in the cytoplasm. Our study demonstrates that ZNF408, previously associated with Familial Exudative Vitreoretinopathy (FEVR), is a new gene causing arRP with vitreous condensations supporting the evidence that this protein plays additional functions into the human retina.
Introduction
Retinitis Pigmentosa (RP [MIM number 268000]) is the most common manifestation of inherited retinal dystrophy, with a worldwide prevalence of 1:4,000 approximately (1) . It is characterized by a progressive degeneration of rod photoreceptors, leading to night blindness and constriction of the visual field, followed by the degeneration of cone photoreceptors, resulting in a total loss of vision.
There is a large variability in the age of onset, progression, retinal appearance and final visual outcome (2) . RP is inherited in all Mendelian forms: autosomal dominant (20% of the cases), autosomal recessive (30%) or X-linked trait (10%). Approximately 40% of patients with RP represent isolated cases; the percentage varies among different populations (3, 4) . NonMendelian inheritance patterns such as digenic, mitochondrial or de novo mutations have been reported, accounting for a small proportion of cases (2) .
To date, more than 70 genes have been associated with RP, being heterogeneous, both clinically and genetically. However, mutations in these genes account for the disease in little over half of all patients thus, remaining genes yet to be identified (4, 5) . Although the function of some of these genes have been extensively studied, it is difficult to establish a precise genotypephenotype correlation because mutations in different RP genes can cause overlapping clinical phenotypes (6) .
The ZNF408 gene encodes a zinc finger protein of 720 amino acids that is predicted to harbor ten C2H2-type finger binding domains thought to be implicated in DNA binding. 4 its implication in vasculature development. In this context, this is the first time the expression and cellular distribution of ZNF408 have been studied in the human retina.
Results

Selected family and summary of the studies performed
Two affected siblings (II:1 and II:2) of a Spanish family (RP-0322), whose parents came from the same and small geographic region ( Figure 1A ), were diagnosed with autosomal recessive RP (arRP). In order to identify the genetic cause underlying the arRP within the family, first we performed whole genome homozygosity mapping using high resolution SNP-array and further whole-exome sequencing (WES) analysis. A previous genotyping study for the index case (II:2) allowed discarding known mutations associated with arRP. Also, direct Sanger sequencing of the coding exons and flanking intronic sequences of EYS did not detect any mutated allele (8) .
Genetic Analysis
Homozygosity mapping and Whole-Exome Sequencing (WES) Analysis. Whole genome homozygosity mapping in II:1 and II:2 of RP-0322 family was performed. The two affected siblings shared four homozygous regions ranging from 2.6 to 1.8 Mb ( Table 1) . These regions contain a total of 193 genes, none of which were previously associated with Retinal Dystrophies (RD).
Subsequently, the index case (II:2) of RP-0322 family was analysed by WES. A total of 88,299,239 reads were uniquely mapped to exonic regions with a median of coverage of 59X (mean coverage 69.5X).
After excluding those variants present in non-coding regions and common variants with a minor allele frequency (MAF) <0.005 at dbSNP, 1000 genomes (1000g) or the Exome Variant Server (EVS) databases, we reduced the number of candidate variants underlying RP from 8,133 to 276 ( Table 2) . Assuming an autosomal recessive inheritance pattern and taking into account a very likely common ancestry in the affected family, homozygous variants lying in the previously identified homozygous regions were prioritized ( Figure 1B) . Due to its implication in vasculature development previously described and its expression in human retina, the ZNF408 gene was selected as a new candidate gene causing arRP.
Sanger sequencing of the specific region confirmed the presence of this variant identified by WES ( Figure 1A ). This variant was not found in 374 ethnically control alleles nor in 1000g or EVS databases.
Screening of the ZNF408 gene in an arRP Spanish cohort. Following this finding, and to determine the prevalence of the ZNF408 mutations as a potential cause of arRP, mutation analysis of the ZNF408 gene was performed by Sanger sequencing in 217 additional Spanish probands affected with sporadic and/or arRP. An additional ZNF408 variant (c.1621C>T; p.Arg541Cys) was found homozygously in a sporadic case from a consanguineous Spanish RP family (II:2, RP-0976, Figure 1A ). This variant was not found in a total of 374 healthy control Spanish chromosomes and in SNP databases (1000g and EVS databases). The Arginine residue at position 541 is localized in the seventh of the ten zinc finger domain and is highly conserved across evolution ( Figure 1B,C) .
Two other novel missense variants, p.Gly492Arg and p.Gln583Lys, were identified in heterozygous state in two other arRP patients. Both missense changes were not present in 75 inhouse exome datasets. These residues are highly conserved ( Figure 1C) . and in silico predictions of the pathogenicity of these two missense variants assessed both of them as deleterious (Table 3) .
In addition, a Comparative Genomic Hybridization array (aCGH) with an exonic coverage ( Figure S1 ) was performed to discard large deletions and copy number variations (CNVs) in the ZNF408 locus in both patients. No second allele was found in these two patients.
The variants p.Gly492Arg and p.Gln583Lys are highly conserved across the evolution ( Figure   1C ) , rendering it possible that these variants affect ZNF408 protein function but are not responsible for the phenotype in these particular patients.
Ophthalmic examination
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The age of onset in all affected individuals (II:1 and II:2, RP-0322 and II:2, RP-0976) was 30, 40 and 17 years, respectively. Night blindness was the first symptom followed by visual field loss and reduction of visual acuity for all patients. At the time of the last ophthalmologic examination, visual fields were symmetrically reduced from 30 to 10 degrees. The best corrected visual acuity (BCVA) ranged from 0.8 to 0.5. Posterior subcapsular cataract was found in all cases. Fundi showed the typical changes of RP with pale optic disc, narrowed vessels, and bone spicule pigmentation (Figure 2A) . Full-field electroretinogram was nonrecordable or substantially reduced. The ophthalmologic data of the patients are summarized in Table 4 .
In order to discard any distinctive sign of FEVR an intravenous fluorescein angiography was performed in homozygous ( Figure 2B ) and heterozygous carriers ( Figure S2 Unfortunately, patients carrying heterozygous p.Gly492Arg and p.Gln583Lys variants were not available for performing additional ophthalmic examination.
ZNF408 is expressed in human retina especially in both cone and rod photoreceptor cells
ZNF408 is abundantly expressed in the human fetal eye as well as in the adult retina, suggesting that ZNF408 has an important role in eye development and visual function (7) . However, its at UNIVERSITAT DE BARCELONA. Biblioteca on http://hmg.oxfordjournals.org/ Downloaded from expression at the protein level and its localization in the human retina have never been investigated. To shed light on these aspects, ZNF408 protein expression and its cellular distribution were assessed using Western blot and immunochemistry assays, respectively, on adult healthy human retina as well as in the 661W photoreceptor cell line.
In the human retina, the outer nuclear layer (ONL), ganglion cell layer (GCL) and both outer and inner plexiform layer (OPL and IPL) showed immunoreactivity against ZNF408 antibodies ( Figure 3A) , being strongest at the ONL level.
In this context, ZNF408 immunolabeling at the ONL level presented intense spots of immunoreactivity located around the nuclei of the photoreceptors ( Figure 3A,B ,F,G) and axon terminals ( Figure 3A ,B,G; arrows). Additionally, the ZNF408 immunostaining pattern exhibited a marked expression in a specific subtype of amacrine cell ( Figure 3H ) and a subtype of ganglion cell of big size, with label in their entire length, including cell body, dendrites and axons ( Figure 3A,B,I ). In addition, ZNF408 immunoreactivity was found in dendrites located in the IPL and in some ganglion cell axons running under the ganglion cell bodies in the nerve fiber layer (NFL) ( Figure 3I ).
To verify that the ZNF408 staining was located at the ONL in rod and cones and not in the As addressed before, ZNF408 is related with FEVR (7). Double immunolabeling using anti-ZNF408 and anti-collagen IV, a specific marker of blood vessels wall, was performed. It is important to remark that the antibody ZNF408 specificity was confirmed by the lack of immunoreactivity in the retina when the antibody was previously preincubated with its blocking peptide ( Figure 3C ).
On the other hand, we performed immunocytochemistry analysis in the mouse retinal photoreceptor-derived 661W cell line. In this context, the ZNF408 immunolabeling exhibited a nuclear and cytoplasmic punctate staining pattern ( Figure 3D ,E). It is important to highlight the ZNF408 staining in nuclei, as expected given that the ZNF408 gene encodes a transcription factor that harbors ten predicted C2H2-type finger binding domains thought to be implicated in DNA binding (7) . In all cases, the staining pattern appeared in the areas of the nucleus The immunoblotting analysis revealed the presence in the human retina and in the 661W cellline samples of a prominent and specific immunoreactive band with an apparent molecular weight of approximately 67 kDa corresponding to the ZNF408 protein ( Figure 3J) . We confirmed the specificity of the antibody by verifying that preadsorption of the antibody with the immunogenic peptide interferes with the ZNF408 detection. The observed size which was lower than the predicted for the isoform encoded by the canonical ZNF408 transcript (78.439 kDa) could be the result of a non-uniform binding of the negatively charged SDS to the protein due to its amino acid composition or the presence of a post-translational cleavage of canonical protein, among others.
Partial mislocalization of WT ZNF408 in presence of mutant p.Arg541Cys protein
Constructs of the wild-type (WT) and the p.His455Tyr mutant together result in mislocalization of the WT ZNF408 in the cytoplasm suggesting oligomerization of ZNF408 WT and mutant proteins (7) . In order to probe the behavior of our arRP-associated p.Arg541Cys variant, similar ZNF408 WT and mutant cotransfection studies were performed. Constructs expressing Nterminal HA-tagged fusion proteins of WT_ZNF408 or the ZNF408_p.Arg541Cys mutant were generated. The analysis of more than 100 cells by immunocytochemistry of transiently transfected COS-1 cells revealed that localization of WT is exclusively restricted to the nucleus.
The p.Arg541Cys mutant ZNF408 also mainly localizes to the nucleus, but occasionally is also present in the cytoplasm of the transfected cells ( Figure 5A,B) . In both cases, the accumulation of both mutants in the cytoplasm were statistically significant. However, the p.Arg541Cys 
Discussion
In this study, we combined homozygosity mapping and whole exome sequencing analysis to identify two novel homozygous mutations in ZNF408 in unrelated Spanish families affected with RP. Furthermore, our functional studies provide evidence for the first association of this gene with inherited Retinal Dystrophy to date. ZNF408 belongs to a large family of transcription factors characterized by an N-terminal a set domain and tandem C-terminal C2H2-type zinc fingers. This gene is highly expressed in human adult and fetal retinal tissues, as was shown by RT-PCR analysis (7), suggesting that ZNF408 could have an important role in retina development and homeostasis.
A heterozygous mutation in ZNF408 has been previously described as cause of FEVR. FEVR is a rare, autosomal dominant inherited disorder characterized by an incomplete vascularization of the peripheral retina and/or retinal blood vessel differentiation.
However, the two RP families described herein did not show any evident sign of FEVR.
Interestingly all affected members of both families presented some vitreous alterations but, the ZNF408-linked RP phenotype of our individuals is completely different from that of FEVR and thus represents a different clinical form caused by mutations in ZNF408. Previous studies have been described posterior vitreous detachment and other vitreous alterations, including fibrillary degenerations, floaters, cottonball-like condensations, nonpigmentary and pigmentary particulation in RP patients (9) (10) (11) . In our patients, the density of the vitreal alterations is higher to the previously described, blurring the fundus resembling the vitreoretinal dystrophies although the morphology is not exactly veils. Therefore, the homozygous mutations described seem to cause a consistent typical RP phenotype with minor vitreous abnormalities other than those found in FEVR patients.
Strikingly, in the RP-0322 family, we have found a homozygous frameshift mutation that it is expected to truncate the ZNF408 protein at its N-terminal, and thus predicted to result in a Since FEVR is inherited as an autosomal dominant manner and it is known that asymptomatic FEVR patients frequently have very early manifestation of the vitreoretinal findings on angiography (12) , an exhaustive ophthalmic examination was performed to exclude any symptom of FEVR in heterozygous carriers of the missense variants found in this study.
However, no vascular alterations were observed in the examined asymptomatic individuals.
It is intriguing how different mutations in ZNF408 could cause distinctive phenotypes of retinal disease with clearly different pathogenic mechanisms and also unequivocal inheritance patterns, such as adFEVR and arRP.
As previously described, the FEVR-associated p.His455Tyr variant could act as dominantnegative mutation. However, although the partial retention of the WT_ZNF408 by the ZNF408_p.Arg541Cys mutant was shown, this is not enough to produce a dominant-negative effect suggesting different mutational mechanisms for these two variants. This hypothesis is also strongly supported by the absence of phenotypic alterations in heterozygous carriers of the p.Arg541Cys mutation, i.e. neither displaying features of arRP nor adFEVR.
Zinc fingers are elements for DNA binding found in a high number of proteins which participate in a wide variety of cellular activities (13) . The greater the number of finger domains, the higher versatility and the more fingers with specific affinity for different ligands in specific classes of proteins (14, 15) . ZNF408 comprises ten of such domains that could have different and still unknown cellular functions in several parts of the organism. The presence of mutations in these different domains suggests these changes are altering the interaction of ZNF408 with specific targets, thereby resulting in the dysregulation of different target genes and subsequently are underlying either FEVR or RP.
Although further studies are mandatory to elucidate the role of ZNF408 in the human retina, it is also important to highlight the ZNF408 staining pattern localizes in the dark areas of the nucleus corresponding with the euchromatin fraction supporting the hypothesis that ZNF408 encodes a Further studies on the identification of the transcriptional targets of ZNF408 could help us to highlight new genes implicated for retinal development that could be good candidates for RD.
Here, in order to identify the disease-causing gene in a Spanish family diagnosed with autosomal recessive RP (arRP), we have performed a combined approach including whole homozygosity mapping followed by a whole exome sequencing analysis (WES). The study revealed the presence of two novel different mutations in the ZNF408 gene in two unrelated arRP Spanish families and thereby expanding the spectrum of ZNF408 mutations to be associated with a new phenotype consisting of RP with vitreous condensations.
Materials and Methods
Patient Recruitment
Patients diagnosed with RP were recruited from the Biobank of the Fundación Jiménez Díaz Hospital (Madrid, Spain). Diagnostic criteria of RP included night blindness and/or peripheral visual loss, with visual field loss and poor visual acuity in advanced stages of the disease. A commercial arRP genotyping microarray v2.0 (AsperBiotech, Tartu, Estonia) was used in the index cases to discard known mutations (20) . A total of 218 unrelated Spanish families with autosomal recessive or sporadic RP were selected. Informed consent was obtained from all patients and family members or their legal guardians involved in the study. All procedures were reviewed and approved by the Ethics Committee of the Hospital and adhered to the tenets of the
Declaration of Helsinki (Fortaleza 2013).
One hundred and eighty seven unrelated individuals of Spanish origin without RP family history were screened as controls to evaluate the frequency of the missense mutation found in this study. 
Genetic Analysis
Homozygosity mapping
A whole-genome homozygosity mapping was performed using Affymetrix 6.0 genotyping arrays (Affymetrix, Inc, Santa Clara, CA). Arrays were processed according to manufacturer's protocols by the Spanish Center for Genotyping (CEGEN, Santiago de Compostela, Spain).
Homozygosity regions were calculated using the Linkage Disequilibrium-Hidden Markov Model algorithm (21) through the dCHIP software (22) . Regions with a size >1Mb were considered candidate regions to harbour the genetic defect.
Next Generation Sequencing (NGS)
Whole-exome sequencing (WES) analysis was performed by the Spanish Centre for Genome Base calling and quality control were performed using the Illumina RTA sequence analysis pipeline. Bioinformatic analysis of the sequencing data was done by the Bioinformatic Platform for Rare Diseases (CIBERER-BIER, http://www.ciberer.es/bier/), using standard tools for quality control, sequence alignment, and variant calling in combination with our own in-house scripts including that of single nucleotide variants (SNVs) and small indels (23) .
Sanger sequencing analysis
Bidirectional automatic sequencing was performed in order to confirm and segregate the obtained results by whole exome sequencing, also to screen the ZNF408 gene in 217 additional arRP families, and to determine the frequency of one of the missense variations in the control population. Exons and exon-intron boundaries of the ZNF408 gene (NM_024741.2) were analyzed using 8 oligonucleotide primers pairs designed using Primer3 software. Sequences and annealing temperatures are available on request. The PCR products were enzymatically purified with ExoSAP-it (USB, Affymetrix) and sequenced using Big Dye Terminator Cycle Sequencing Kit version 1.1 (Applied Biosystems, Carlsbad, CA). The PCR products were resolved on an automated sequencer (ABI 3130xl Genetic Analyzer, Applied Biosystems).
Sequencing results were analyzed by using Staden Package 1.7.0 software by assembling and visualizing the aligned sequences of the exons. 
Prediction of the pathogenic effect of the variants
Comparative Genomic Hybridization array (aCGH)
The custom aCGH 8X60k using Agilent SurePrint G3 CGH was designed using the Agilent eArray website (https://earray.chem.agilent.com/earray/) with an average distribution of 1 probe per 150pb in the ZNF508 gene.
Briefly, genomic DNA (200ŋg) from the patient and from a sex-matched control were digested by Alu I and Rsa I restriction enzymes for 2 h at 37°C and the digested products were labeled with Cy3-dUTP and Cy5-dUTP fluorochromes using the Sure Tag DNA Labeling Kit (Agilent Technologies). The labeled products were purified, hybridized and washed according to Agilent protocols. The slide was scanned on a SureScan G4900DA scanner (Agilent Technologies), and the resulting TIFF images were converted by the image conversion Feature Extraction software (Agilent Technologies). Results were analyzed by Agilent CytoGenomics software v.2.7 using default analysis method -CGH v2 with the ADM-2 aberration algorithm.
Ophthalmic examination
Ophthalmic examinations were performed for all patients with mutations in ZNF408 and the available heterozygous carriers. The evaluation included visual acuity, intraocular pressure, ocular motility, pupillary reaction, biomicroscopic slit lamp examination and dilated fundus examination. Visual function was evaluated by static perimetry and Ganzfeld electroretinography according to the ISCEV (International Society for Clinical Electrophysiology of Vision) (24) . An intravenous fluorescein angiography (IVFA) was performed.
Immunohistochemistry
The ZNF408 localization pattern was determined in cryo-fixed healthy adult human retina sections. They were immunostained at room temperature overnight with rabbit polyclonal antibodies to human ZNF408 from Santa Cruz Biotechnology (Santa Cruz, CA, USA; Catalog School of Medicine; Atlanta, GA, USA) (25, 26) . In addition, the 661W photoreceptor cell-line was also probed with the ZNF408 antibodies.
Furthermore, ZNF408 protein expression was assessed using Western blotting on adult healthy human retinas as well as in the 661W photoreceptor cell-line. Briefly, proteins were extracted and subjected to immunoblotting analysis. Proteins (40 μg/lane) were resolved by SDS-PAGE on 4-20% polyacrylamide-gradient gels and electrotransferred to Hybond-P PVDF membranes (GE Healthcare, Buckinghamshire, UK). These were probed at 4 °C overnight with the same ZNF408 antibodies used in immunocytochemistry assays at a 1:100 dilution in 25 mM Tris (pH 8.0), 150 mM NaCl, 2.7 mM KCl (TBS) in the presence or absence of blocking peptide (10:1 peptide: antibody ratio; LifeTein South Plainfield NJ, USA), or with mouse monoclonal antibodies to rabbit muscle GAPDH at a 1:1,000 dilution (Millipore, Temecula, CA, USA; Catalog No. MAB374). Thereafter, the membranes were incubated at room temperature for 1 h with horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse (Pierce, Rockford, IL, USA) IgG at a 1:20,000 dilution. Detection was performed by enhanced chemiluminescence using the SuperSignal West Dura system (Pierce).
Transfection of COS-1 Cells
Constructs expressing HA-tagged or eCFP-tagged WT and mutant ZNF408 were designed using the mammalian expression vector pcDNA3-HA/DEST or pcDNA3-eCFP/DEST, both driven by a cytomegalovirus (CMV) promoter.
COS-1 cells where transiently transfected using Effectene (Qiagen) according to the manufacturer´s instructions. In both cases, unpaired Student's t-test as well as Mann-Whitney analyses were used to determine if there were statistically significant differences. Images were obtained with a Zeiss AxioImager Z1 upright fluorescent microscope and processed with a Zeiss ApoTome slider module. All experiments were performed in duplicate (7). 
